Atul Deodhar
- Rheumatology top 0.2%
- Immunology top 1%
- Hematology top 1%
- Orthopedics and Sports Medicine top 5%
- Genetics top 10%
- Co-authors
- Désirée van der HeijdeAbhijeet DanveJürgen BraunJoachim SieperXenofon BaraliakosBrian PorterHanno B. RichardsKeith S. Kanik
- Topics
- Spondyloarthritis Studies and Treatments (103 papers)Rheumatoid Arthritis Research and Therapies (75 papers)Psoriasis: Treatment and Pathogenesis (66 papers)
- Cited by
- RheumatologyHematologyImmunology
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Atul Deodhar
115 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Rheumatology 2.5k
- Immunology 1.7k
- Hematology 1.0k
- Orthopedics and Sports Medicine 243
- Genetics 204
Countries citing papers authored by Atul Deodhar
This map shows the geographic impact of Atul Deodhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atul Deodhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atul Deodhar more than expected).
Fields of papers citing papers by Atul Deodhar
This network shows the impact of papers produced by Atul Deodhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atul Deodhar. The network helps show where Atul Deodhar may publish in the future.
Co-authorship network of co-authors of Atul Deodhar
This figure shows the co-authorship network connecting the top 25 collaborators of Atul Deodhar. A scholar is included among the top collaborators of Atul Deodhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atul Deodhar. Atul Deodhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 8 | |
| 11 | 1 | |
| 12 | 3 | |
| 13 | 79 | |
| 14 | 32 | |
| 15 | 97 | |
| 16 | 11 | |
| 17 | 30 | |
| 18 | Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging studybreakdown → | 272 |
| 19 | Achieving Ankylosing Spondylitis Disease Activity Score-C-Reactive Protein Major Improvement and Inactive Disease in Patients with Ankylosing Spondylitis after Treatment with Golimumab is Associated with Normalized Health Related Quality of Life: 2-Year Results from GO-RAISE | 1 |
| 20 | Sustained Clinical Response with Golimumab Administered Subcutaneously Every 4 Weeks in Ankylosing Spondylitis: 104-Week Results of a Randomized, Placebo-Controlled Study | 1 |
About Atul Deodhar
Atul Deodhar is a scholar working on Rheumatology, Hematology and Immunology, having authored 125 papers that have together received 3.0k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (103 papers), Rheumatoid Arthritis Research and Therapies (75 papers) and Psoriasis: Treatment and Pathogenesis (66 papers). The work is most often cited by research in Rheumatology (2.5k citations), Hematology (1.0k citations) and Immunology (1.7k citations). Atul Deodhar has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Désirée van der Heijde, Abhijeet Danve, Jürgen Braun, Joachim Sieper, Xenofon Baraliakos, Brian Porter, Hanno B. Richards, Keith S. Kanik, Sujatha Menon and Dona Fleishaker. Their work appears in journals such as The Lancet, JAMA and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.